RxDoctor Payments Data
★ My doctorsLook up a doctor →

Lisa Evans

Hematology & Oncology · New Albany, INNPI 1831782044

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 95.2% of the total across 199 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 49 manufacturers, the largest accounting for just 11.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $1,351 and has fallen 88.6% since, to $154 in 2025. That places this record below the midpoint for hematology & oncology clinicians in IN, where the typical reported total is $3,829.

$3,764in general payments, 2019–2025

Across 199 payments — averaging $18.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$447
  • AbbVie$361
  • Seagen Inc.$259
  • Pfizer$200
  • Alkermes, Inc.$160
  • Bristol Myers Squibb$141
  • plus $2K from 43 others

What the payments were for

  • Food & beverage$3,58595%
  • Education$1795%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novartis31$447
AbbVie22$361
Seagen Inc.9$259
Pfizer8$200
Alkermes, Inc.3$160
Bristol Myers Squibb4$141
Incyte Corporation4$138
Amgen9$129
Merz North America, Inc.1$123
Sanofi7$112
Eisai Inc.7$110
Lilly USA, LLC7$107
AstraZeneca6$106
Johnson & Johnson7$94
GSK6$87
Idorsia Pharmaceuticals US Inc4$79
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)4$79
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC5$77
E.r. Squibb & Sons, L.L.C.5$73
Stryker1$72
Orexo US, Inc.4$72
Daiichi Sankyo Inc.4$66
Merck3$55
Tersera Therapeutics LLC3$54
Novo Nordisk3$48
Ipsen Biopharmaceuticals, Inc3$47
Boehringer Ingelheim3$43
Regeneron Healthcare Solutions, Inc.2$41
Takeda Pharmaceuticals U.S.A., Inc.2$40
Genentech USA, Inc.3$40
Indivior Inc.1$27
TG Therapeutics, Inc.1$23
Blueprint Medicines Corporation1$23
Abiomed1$22
Vanda Pharmaceuticals Inc.1$20
AMAG Pharmaceuticals, Inc.1$18
Novocure Inc.1$15
Mayne Pharma Commercial LLC1$15
Baxter Healthcare1$14
Mylan Specialty L.p.1$14
Acceleron Pharma, Inc.1$14
Dova Pharmaceuticals1$14
Pharmacyclics LLC, An Abbvie Company1$14
Arbor Pharmaceuticals, Inc.1$13
Morphosys, US Inc.1$13
Gilead1$12
Puma Biotechnology, Inc.1$12
Karyopharm Therapeutics Inc.1$12
Impel Pharmaceuticals Inc.1$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,764 in reported general payments places this provider in the 45th percentile of 224 hematology & oncology providers in Indiana.

See all hematology & oncology providers in Indiana →

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin14$313
Metoprolol Succinate14$228
Omeprazole15$82
Lisinopril16$63

Paid to pharmacies, not to this prescriber.

Other hematology & oncology in New Albany

See the full list for Indiana →

Where these figures come from

Is this you, or does something look wrong? →